BUTABARBITAL SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Butabarbital Sodium, and what generic alternatives are available?
Butabarbital Sodium is a drug marketed by Wockhardt, Sandoz, Solvay, Teva, Watson Labs, and Whiteworth Town Plsn. and is included in fifteen NDAs.
The generic ingredient in BUTABARBITAL SODIUM is butabarbital sodium. There are nine drug master file entries for this compound. Additional details are available on the butabarbital sodium profile page.
Summary for BUTABARBITAL SODIUM
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 15 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Clinical Trials: | 1 |
Patent Applications: | 296 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BUTABARBITAL SODIUM at DailyMed |
Recent Clinical Trials for BUTABARBITAL SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |